Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine (Q36772839)

16 August 2017

1 reference

title

Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine (English)

1 reference

16 August 2017

1 reference

Jim Kaput

1

1 reference

16 August 2017

Alla Perlina

2

1 reference

16 August 2017

Betul Hatipoglu

3

1 reference

16 August 2017

Amelia Bartholomew

4

1 reference

16 August 2017

Yuri Nikolsky

5

1 reference

16 August 2017

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

4

1 reference

16 August 2017

369-390

1 reference

The multiethnic cohort study: exploring genes, lifestyle and cancer risk

16 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nutritional genomics: the next frontier in the postgenomic era

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nutrigenomics and nutrigenetics: the emerging faces of nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Genetic variation, classification and 'race'

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Whole-genome patterns of common DNA variation in three human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Lower Bronchodilator Responsiveness in Puerto Rican than in Mexican Subjects with Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Molecular basis of ethnic differences in drug disposition and response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Identification of a variant associated with adult-type hypolactasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Common polymorphism in a highly variable region upstream of the human lactase gene affects DNA-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Convergent adaptation of human lactase persistence in Africa and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Genetics of Lactase Persistence and Lactose Intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Diet-disease gene interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Principles for the buffering of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Epistasis: too often neglected in complex trait studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nutrigenomics: exploiting systems biology in the nutrition and health arena

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The quest for cardiovascular health in the genomic era: nutrigenetics and plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The metabolic syndrome: a crossroad for genotype-phenotype associations in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Multidimensional genome scans identify the combinations of genetic loci linked to diabetes-related phenotypes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Pharmacogenomics in the Americas: the impact of genetic admixture.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Modulation of human immune and inflammatory responses by dietary fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

A genome-wide association study identifies novel risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Admixture-matched case-control study: a practical approach for genetic association studies in admixed populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Reconstructing genetic ancestry blocks in admixed individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Population stratification confounds genetic association studies among Latinos

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Comparison of three methods to estimate genetic ancestry and control for stratification in genetic association studies among admixed populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Epigenetic reprogramming in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Epigenetics and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Epigenetic regulation of mammalian genomic imprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

S-adenosylmethionine: DNA-cytosine 5-methyltransferase from a Novikoff rat hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The Sir2 family of protein deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Chromatin remodeling and tissue-selective responses of nuclear hormone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Advances in chromatin remodeling and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Developmental origins of the metabolic syndrome: prediction, plasticity, and programming

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nutritional aspects in the causation and management of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The role of antioxidant micronutrients in the prevention of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Diabetes preventive components in the Mediterranean diet

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Identification of amino acids in rat pregnane X receptor that determine species-specific activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Assessing the function of genetic variants in candidate gene association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Type 2 diabetes: principles of pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Activating mutations in the ABCC8 gene in neonatal diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Membrane ion channels and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Toxicology of oral antidiabetic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Applications of AmpliChip CYP450.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Genetic variation and lipid metabolism: modulation by dietary factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Why most published research findings are false

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

A road map for efficient and reliable human genome epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

SINGLE NUCLEOTIDE POLYMORPHISMS THAT INFLUENCE LIPID METABOLISM: Interaction with Dietary Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

PPAR signaling in the control of cardiac energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Peroxisome proliferator-activated receptors: insight into multiple cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

An overview on biological mechanisms of PPARs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Application of nutrigenomic concepts to Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The e subunit gene of murine F1F0-ATP synthase. Genomic sequence, chromosomal mapping, and diet regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The case for strategic international alliances to harness nutritional genomics for public and personal health

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nonlinear dimensionality reduction by locally linear embedding

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

A global geometric framework for nonlinear dimensionality reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Non-linear mapping for exploratory data analysis in functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Modelling the dynamics of biosystems.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Sample phenotype clusters in high-density oligonucleotide microarray data sets are revealed using Isomap, a nonlinear algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Peroxisome proliferator-activated receptors in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

PPARgamma2 pro12Ala polymorphism and insulin resistance in Japanese hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Transcription, adipocyte differentiation, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Activation of PPARgamma increases PTEN expression in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

An autosomal genome-wide scan for loci linked to pre-diabetic phenotypes in nondiabetic Chinese subjects from the Stanford Asia-Pacific Program of Hypertension and Insulin Resistance Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Genetic and environmental factors influencing fasting serum adiponectin in Hispanic children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nutritional regulation of visceral markers in rat liver and cultured hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Induction of CYP3A by ethanol in multiple in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Dietary fat and postprandial lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Dietary polyunsaturated fatty acids and regulation of gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Interaction between a peroxisome proliferator-activated receptor gene polymorphism and dietary fat intake in relation to body mass

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Liver X receptor preferentially activates de novo lipogenesis in human preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

A teleost in vitro reporter gene assay to screen for agonists of the peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The role of sulphonylureas in the management of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Cell protection through PPAR nuclear receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Interdomain communication regulating ligand binding by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Regulation of uncoupling protein-2 mRNA in L6 myotubules: I: Thiazolidinediones stimulate uncoupling protein-2 gene expression by a mechanism requiring ongoing protein synthesis and an active mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Evidence that 12-lipoxygenase product 12-hydroxyeicosatetraenoic acid activates p21-activated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Activation of heat shock transcription factors by delta 12-prostaglandin J2 and its inhibition by intracellular glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Yin-yang: balancing act of prostaglandins with opposing functions to regulate inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

An Icelandic example of the impact of population structure on association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Demonstrating stratification in a European American population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

Gene-Environment Interactions: Defining the Playfield

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.369

21 January 2018

Identifiers

DOI

10.2217/14622416.8.4.369

1 reference

16 August 2017

1 reference